The deal values each Covidien share at $93.22, paid for by $35.19 in cash and 0.956 Medtronic shares. The transaction represents a 29 percent premium to Covidien's closing stock price on Friday, Medtronic said
to keep it short
price before announcement $72 .
29% premium
we cant compare literally " IF " in the next year or 2 , medtronic or another mega company swoops in for SSH , as were a micro cap , and the example above , the company was valued at $32b
the point im trying to make is the importance of SSH being in a high price level when any such announcement whether its fda approval or a buyout.
we should be looking to be above 30 when the time comes , sadly all this seems like far fetched
the positive aspect of the mentioned deal above , is that in the future if an offer was to be made , a billion or 2 or 3 would be peanuts to medtronic or another mega company !
lets just hope the board and management of SSH value the company as high as our expectations
we look @ the current stock price and we say well its early days .. but the truth is , were past the halfway line
thoughts?
Add to My Watchlist
What is My Watchlist?